Adaptability of an Undetectable = Untransmissible Model for HBV

Recruiting Observational Study
Chronic Hepatitis b Viremia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
55 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Infected Individuals * Individuals above 18 years and less than 65 years with chronic hepatitis B infection * Included according to undermentioned three arms: * Infected, On-treatment arm: subjects being treated with TAF/TDF for a minimum of 2 years with sustained viral supp…
Contacts

AnnMarie Liapakis, MD

212-263-3751

AnnMarie.Liapakis@nyulangone.org

CONTACT